Ohannes K Melemedjian Selected Research

Ohannes K Melemedjian Research Topics

Disease

11	Pain (Aches) 01/2019 - 11/2010
8	Hyperalgesia 01/2019 - 05/2011
6	Hypersensitivity (Allergy) 01/2017 - 11/2010
5	Chronic Pain 01/2017 - 11/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 03/2008
3	Neuralgia (Stump Neuralgia) 01/2019 - 09/2011
3	Peripheral Nerve Injuries 01/2017 - 09/2011
2	Surgical Wound 07/2015 - 01/2012
2	Headache (Headaches) 07/2014 - 01/2012
1	Hypoxia (Hypoxemia) 01/2019
1	Cold Hypersensitivity 01/2017
1	Postoperative Pain 07/2015
1	Neoplasms (Cancer) 07/2013
1	Migraine Disorders (Migraine) 01/2012
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2012
1	Inflammation (Inflammations) 11/2010
1	Chronic Pancreatitis 11/2010
1	Pancreatitis 11/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2004

Drug/Important Bio-Agent (IBA)

7	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2010
4	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2011
3	Phosphotransferases (Kinase)IBA 01/2017 - 01/2012
3	Protein Kinases (Protein Kinase)IBA 07/2013 - 09/2011
3	Adenosine Monophosphate (AMP)IBA 07/2013 - 09/2011
2	Bortezomib (Velcade)FDA Link 01/2019 - 01/2019
2	Nerve Growth Factor (NGF)IBA 01/2017 - 11/2010
2	CarrageenanIBA 01/2017 - 07/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 01/2012
2	Peptides (Polypeptides)IBA 07/2015 - 06/2012
2	CytokinesIBA 01/2012 - 11/2010
2	AMP-Activated Protein KinasesIBA 01/2012 - 09/2011
2	Eukaryotic Initiation Factor-4F (EIF4F)IBA 09/2011 - 11/2010
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Lactate Dehydrogenase 5IBA 01/2019
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2019
1	CalciumIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Eukaryotic Initiation Factor-4EIBA 01/2017
1	RNA Cap-Binding Proteins (Cap Binding Protein)IBA 01/2017
1	cercosporamideIBA 01/2017
1	Freund's AdjuvantIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	CannabinoidsIBA 01/2016
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 01/2016
1	Calcium Channels (Calcium Channel)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 07/2014
1	Protein Synthesis InhibitorsIBA 07/2014
1	Dyneins (Dynein)IBA 07/2014
1	OligonucleotidesIBA 07/2014
1	Conditioned Culture MediaIBA 07/2014
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2013
1	TOR Serine-Threonine KinasesIBA 07/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2013
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2012
1	U 0126 (UO 126)IBA 01/2012
1	ResveratrolIBA 01/2012
1	Dinoprostone (PGE2)FDA Link 01/2012
1	Fragile X Mental Retardation ProteinIBA 01/2012
1	Sodium Channels (Sodium Channel)IBA 09/2011
1	4- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA 09/2011
1	Prostaglandins EIBA 05/2011
1	ProstaglandinsIBA 05/2011
1	3,4-dihydroxyphenylglycolIBA 05/2011
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 05/2011
1	metabotropic glutamate receptor type 1IBA 05/2011
1	Nerve Growth Factors (Neurotrophins)IBA 11/2010
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2010
1	20,21-epoxyresibufogenin-3-formateIBA 11/2010
1	Analgesics (Analgesic Drugs)IBA 11/2010
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2010
1	dibutyldichlorotinIBA 11/2010
1	CaspasesIBA 07/2004

Therapy/Procedure

6	Therapeutics 07/2015 - 03/2008
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
2	Spinal Injections 07/2014 - 05/2011
1	Ligation 06/2012
1	Intravenous Administration 03/2008